13F HOLDINGS REPORT
TRV GP IV, LLC
Quarter ended Q2 2025 · Filed August 8, 2025 · Accession 0000950123-25-007372
Total Value
$163.3M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TANGO THERAPEUTICS, INC. | TNGX | 16,859,075 | $86.3M | 52.85% |
| 2 | MAZE THERAPEUTICS, INC. | MAZE | 6,073,958 | $74.5M | 45.63% |
| 3 | PLIANT THERAPEUTICS, INC. | PLRX | 2,132,867 | $2.5M | 1.51% |